Watch a compelling conference talk from SK TECH SUMMIT 2023 exploring how ImpriMed, a Silicon Valley medical startup, is revolutionizing cancer treatment through precision medicine. Learn about their journey developing AI models that predict drug responses and help identify optimal cancer treatments, starting with successful commercialization in the US pet market for dogs with cancer. Discover how the data collected from thousands of canine patients and their AI technology can be translated to improve treatment outcomes for human cancer patients. The presentation is delivered by Sungwon Lim, ImpriMed's co-founder and CEO, who holds degrees from KAIST, UC Berkeley-UCSF, and Stanford, and was recognized with the 40 Under 40 in Cancer award in 2022.
Overview
Syllabus
[SK TECH SUMMIT 2023] 암환자 개개인에 맞는 항암치료제 찾기: 반려동물에서 사람으로
Taught by
SK AI SUMMIT 2024